EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Financial Indicator Details
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ ONO PHARMACEUTICAL +
@ TSUMURA & CO. +
@ Hitachi Chemical +
@ ダイセル +
@ キョーリン製薬ホールディングス +
@ 富士製薬工業 +
@ 千寿製薬 +
@ ROHTO PHARMACEUTICAL +
@ Sekisui Chemical +
@ Nissan Chemical Industries +
@ アステラス製薬 +
@ エスケー化研 +
@ ADEKA +
@ 持田製薬 +
@ 長谷川香料 +
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Nissan Motor
graph
PIONEER etc.
graph
日本セラミック
graph
日本セラミック
graph
日本セラミック
graph

Financial Indicator Details: Fuso Pharmaceutical Industries (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

*Free Download Financial Indicator data

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability2009-03-312010-03-312011-03-312012-03-312013-03-31
Net profit margin
(Industry Average)
-2.02%
(-12.05%)
1.11%
(-0.50%)
2.40%
(1.53%)
0.83%
(-1.67%)
10.02%
(3.05%)
C/F margin
(Industry Average)
2.57%
(-3.31%)
4.69%
(8.51%)
14.62%
(7.04%)
1.99%
(6.35%)
6.70%
(8.25%)
ROA
(Industry Average)
-1.45%
(0.52%)
0.81%
(1.04%)
1.92%
(2.07%)
0.60%
(0.06%)
6.77%
(2.71%)
ROE
(Industry Average)
-3.61%
(-1.43%)
2.00%
(0.03%)
4.35%
(2.96%)
1.39%
(4.68%)
14.71%
(4.57%)
Growth2009-03-312010-03-312011-03-312012-03-312013-03-31
Equity growth
(Industry Average)
-
(-)
0.45%
(5.01%)
1.44%
(2.61%)
1.27%
(-0.40%)
24.43%
(8.16%)
Sales growth
(Industry Average)
-
(-)
1.43%
(-2.67%)
1.95%
(5.36%)
-6.55%
(1.07%)
9.59%
(2.24%)
Net profit growth
(Industry Average)
-
(-)
155.63%
(203.46%)
120.84%
(63.25%)
-67.48%
(3.89%)
1,209.40%
(90.38%)
Operating C/F growth
(Industry Average)
-
(-)
84.78%
(275.10%)
217.65%
(35.09%)
-87.26%
(-6.09%)
268.55%
(138.39%)
Stability2009-03-312010-03-312011-03-312012-03-312013-03-31
Capital adequacy
(Industry Average)
40.33%
(53.80%)
40.68%
(54.51%)
44.17%
(55.00%)
43.22%
(53.59%)
46.06%
(56.30%)
Liquidity ratio
(Industry Average)
114.82%
(217.72%)
121.07%
(225.70%)
129.23%
(237.55%)
132.30%
(239.89%)
148.51%
(236.21%)
C/F ratio current liabilities
(Industry Average)
2,347.33%
(777.21%)
1,251.05%
(303.31%)
335.44%
(434.79%)
2,745.70%
(929.73%)
845.15%
(573.30%)
Quick ratio
(Industry Average)
87.78%
(138.97%)
88.48%
(148.85%)
98.20%
(156.17%)
97.73%
(160.84%)
115.25%
(156.81%)
Turnover2009-03-312010-03-312011-03-312012-03-312013-03-31
Receivables turnover
(Industry Average)
168.69day
(83.89day)
165.10day
(94.27day)
146.41day
(93.96day)
159.99day
(97.92day)
169.80day
(98.27day)
Inventory turnover
(Industry Average)
49.59day
(54.45day)
58.37day
(52.58day)
49.69day
(52.64day)
60.43day
(56.59day)
61.92day
(58.68day)
Payable turnover
(Industry Average)
92.01day
(45.01day)
93.58day
(49.82day)
86.49day
(49.52day)
93.36day
(52.10day)
91.43day
(51.12day)
Working capita turnover
(Industry Average)
126.27day
(93.32day)
129.89day
(97.02day)
109.61day
(97.08day)
127.06day
(102.41day)
140.28day
(105.83day)
Stock etc.2009-03-312010-03-312011-03-312012-03-312013-03-31
Market Value growth
(Industry Average)
-
(-)
11.27%
(34.57%)
-18.95%
(1.49%)
-7.65%
(-3.85%)
81.22%
(21.16%)
Dividend Yield
(Industry Average)
2.08%
(3.20%)
1.87%
(1.93%)
2.31%
(2.17%)
2.50%
(2.45%)
1.38%
(2.07%)
PER
(Industry Average)
-27.91%
(25.22%)
55.83%
(23.06%)
20.48%
(16.22%)
58.18%
(29.19%)
8.05%
(16.58%)
PBR
(Industry Average)
1.00%
(0.86%)
1.11%
(1.06%)
0.89%
(1.04%)
0.81%
(0.95%)
1.18%
(1.08%)
PCFR
(Industry Average)
21.96%
(7.18%)
13.22%
(9.23%)
3.37%
(-2.43%)
24.48%
(9.50%)
12.03%
(7.56%)
PSR
(Industry Average)
0.56%
(0.77%)
0.62%
(0.88%)
0.49%
(1.10%)
0.48%
(0.90%)
0.80%
(1.01%)

Financial Indicator Details: Fuso Pharmaceutical Industries

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Profitability
Net profit margin-2.02%1.11%2.40%0.83%10.02%
C/F margin2.57%4.69%14.62%1.99%6.70%
ROA-1.45%0.81%1.92%0.60%6.77%
ROE-3.61%2.00%4.35%1.39%14.71%
Recurring margin0.18%0.10%3.45%0.16%7.74%
EBIT margin0.26%1.85%2.69%0.59%13.36%
EBITDA margin4.95%6.60%7.09%4.84%16.96%
NOPAT margin0.15%1.11%1.61%0.35%8.01%
Sales SG rates69.82%70.14%70.93%72.51%68.49%
Sales SG&A rates29.50%28.85%24.51%26.40%23.65%
Sales R&D expenses rates8.02%----
Sales depreciation rates4.68%4.75%4.39%4.25%3.59%
Capital expenditures net sales ratio-5.20%-2.51%-2.13%-2.71%-3.96%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Growth
Growth rate of cash--0.79%22.18%11.60%113.18%
Equity growth-0.45%1.44%1.27%24.43%
Total assets growth--0.41%-6.56%3.49%16.77%
Sales growth-1.43%1.95%-6.55%9.59%
Net profit growth-155.63%120.84%-67.48%1,209.40%
Operating C/F growth-84.78%217.65%-87.26%268.55%
Recurring profit growth--40.69%3,119.60%-95.49%4,986.48%
EBIT growth-607.37%48.31%-79.53%2,379.00%
EBITDA growth-35.26%9.49%-36.16%283.48%
NOPAT growth-607.37%48.31%-79.53%2,379.00%
Operating expenses growth-----
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Stability
Capital adequacy40.33%40.68%44.17%43.22%46.06%
Liquidity ratio114.82%121.07%129.23%132.30%148.51%
C/F ratio current liabilities2,347.33%1,251.05%335.44%2,745.70%845.15%
Quick ratio87.78%88.48%98.20%97.73%115.25%
Fixed ratio103.40%96.67%91.63%89.16%67.95%
D/E ratio64.30%62.73%45.69%50.72%39.91%
Loan to Value Ratio25.93%25.52%20.18%21.92%18.38%
Business investment C/F ratio-202.02%-53.56%-14.61%-136.42%-59.17%
Liabilities with interest growth--1.99%-26.10%12.41%-2.08%
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Turnover
Cash turnover25.14day24.59day29.47day35.20day68.47day
Receivables turnover168.69day165.10day146.41day159.99day169.80day
Inventory turnover49.59day58.37day49.69day60.43day61.92day
Fixed assets turnover211.91day196.20day185.05day195.15day168.86day
Total asset turnover508.05day498.80day457.14day506.28day539.47day
Payable turnover92.01day93.58day86.49day93.36day91.43day
Capital turnover85.54day84.33day82.72day88.52day80.77day
Equity turnover204.93day202.95day201.94day218.86day248.50day
Working capita turnover126.27day129.89day109.61day127.06day140.28day
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Balance sheet
Cash etc.¥ 3 B¥ 3 B¥ 3 B¥ 4 B¥ 9 B
Accounts receivable-trade¥ 21 B¥ 21 B¥ 19 B¥ 19 B¥ 22 B
Other Current Assets¥ 28 B¥ 29 B¥ 26 B¥ 27 B¥ 31 B
Current Assets¥ 31 B¥ 33 B¥ 30 B¥ 32 B¥ 40 B
Tangible Assets¥ 26 B¥ 25 B¥ 24 B¥ 23 B¥ 22 B
Intangible Assets¥ 248 M¥ 200 M¥ 201 M¥ 166 M¥ 376 M
Investment etc.¥ 5 B¥ 5 B¥ 5 B¥ 5 B¥ 8 B
Total Assets¥ 63 B¥ 63 B¥ 59 B¥ 61 B¥ 71 B
Current Liabilities¥ 27 B¥ 27 B¥ 23 B¥ 24 B¥ 27 B
Fixed Liabilities¥ 10 B¥ 10 B¥ 9 B¥ 10 B¥ 11 B
Liabilities with interest¥ 16 B¥ 16 B¥ 12 B¥ 13 B¥ 13 B
Net Assets¥ 25 B¥ 25 B¥ 26 B¥ 26 B¥ 33 B
Capital stock¥ 10 B¥ 10 B¥ 10 B¥ 10 B¥ 10 B
Capital surplus etc.¥ 15 B¥ 15 B¥ 15 B¥ 15 B¥ 22 B
Liabilities and net assets¥ 63 B¥ 63 B¥ 59 B¥ 61 B¥ 71 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Income statement
Sales¥ 45 B¥ 46 B¥ 47 B¥ 44 B¥ 48 B
Cost of Sales¥ 32 B¥ 32 B¥ 33 B¥ 32 B¥ 33 B
Gross profit¥ 13 B¥ 13 B¥ 13 B¥ 12 B¥ 15 B
Other income¥ 393 M¥ 1 B¥ 435 M¥ 594 M¥ 3 B
SG&A¥ 13 B¥ 13 B¥ 11 B¥ 11 B¥ 11 B
Other expenses¥ 1 B¥ 1 B¥ 1 B¥ 703 M¥ 2 B
Net income¥ -931 M¥ 518 M¥ 1 B¥ 372 M¥ 4 B
Operating income¥ 296 M¥ 463 M¥ 2 B¥ 480 M¥ 3 B
Ordinary Income¥ 86 M¥ 51 M¥ 1 B¥ 74 M¥ 3 B
EBITDA¥ 2 B¥ 3 B¥ 3 B¥ 2 B¥ 8 B
Income before income taxes¥ -151 M¥ 573 M¥ 984 M¥ 6 M¥ 6 B
Depreciation¥ 2 B¥ 2 B¥ 2 B¥ 1 B¥ 1 B
R&D expenses¥ 3 B----
Income taxes¥ 779 M¥ 54 M¥ -160 M¥ -365 M¥ 1 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Cash flow statement
Operating CF¥ 1 B¥ 2 B¥ 6 B¥ 884 M¥ 3 B
Investment CF¥ -2 B¥ -1 B¥ -1 B¥ -1 B¥ 2 B
Financial CF¥ 55 M¥ -878 M¥ -4 B¥ 943 M¥ -832 M
Foreign Exchange Effects¥ -6 M¥ -6 M¥ -13 M¥ -1 M-
Net Change in Cash¥ -1 B¥ -125 M¥ 795 M¥ 445 M¥ 4 B
Free CF¥ -1 B¥ 760 M¥ 5 B¥ -498 M¥ 5 B
Capital expenditures¥ -2 B¥ -1 B¥ -1 B¥ -1 B¥ -1 B
Cash dividends paid¥ -542 M¥ -541 M¥ -542 M¥ -542 M¥ -542 M
Repayment loans¥ -2 B¥ -3 B¥ -3 B¥ -3 B¥ -3 B
Indicator 2009-03-312010-03-312011-03-312012-03-312013-03-31
Shareowners' equity
Issuance of new shares-----
Dividends from surplus¥ -543 M¥ -543 M¥ -543 M¥ -543 M¥ -543 M
Net income¥ -931 M¥ 518 M¥ 1 B¥ 372 M¥ 4 B
Purchase of treasury stock¥ -20 M¥ -7 M¥ -8 M¥ -3 M¥ -5 M
Other Change in Stockholders Equity¥ -1 M¥ 74 M¥ 1 M-¥ 312 M
Other Change in Net Assets¥ -735 M¥ 75 M¥ -221 M¥ 509 M¥ 1 B
Net Change in Net Assets¥ -2 B¥ 117 M¥ 373 M¥ 335 M¥ 6 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Fuso Pharmaceutical Industries (Annual )

Statement Type
Annual : Fuso Pharmaceutical Industries
First quarter : Fuso Pharmaceutical Industries
Second quarter : Fuso Pharmaceutical Industries
Third quarter : Fuso Pharmaceutical Industries
Analysis Menu
@Outline : Fuso Pharmaceutical Industries
@Statement : Fuso Pharmaceutical Industries
@Rating : Fuso Pharmaceutical Industries
@Indicator : Fuso Pharmaceutical Industries
@Download : Fuso Pharmaceutical Industries
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ Fuso Pharmaceutical Industries 4538 TSE 1st Chemicals 3 Annual BBB

Related Company

@ 長谷川香料 (Sales ¥ 45 B) +
@ Dainippon Sumitomo Pharma (Sales ¥ 347 B) +
@ NIPPON KAYAKU (Sales ¥ 128 B) +
@ Takeda Pharmaceutical (Sales ¥ 1.5 T) +
@ エスケー化研 (Sales ¥ 82 B) +
@ Otsuka Holdings (Sales ¥ 1.2 T) +
@ ROHTO PHARMACEUTICAL (Sales ¥ 129 B) +
@ ダイセル (Sales ¥ 358 B) +
@ TSUMURA & CO. (Sales ¥ 105 B) +
@ 持田製薬 (Sales ¥ 89 B) +
@ Fuso Pharmaceutical Industries (Sales ¥ 48 B) +
@ 富士製薬工業 (Sales ¥ 25 B) +
@ 千寿製薬 (Sales ¥ 28 B) +

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.114 sec.)